Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by TD Cowen from $1,020.00 to $1,030.00 in a report published on Wednesday morning, Benzinga reports. TD Cowen currently has a buy rating on the biopharmaceutical company’s stock. Several other equities analysts have also recently weighed in on REGN. StockNews.com cut shares of Regeneron […]
Tokio Marine Asset Management Co. Ltd. raised its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 3.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,420 shares of the biopharmaceutical company’s stock after acquiring an additional 81 shares during […]
Tokio Marine Asset Management Co. Ltd. raised its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 3.5% in the 4th quarter, HoldingsChannel.com reports. The firm owned 2,420 shares of the biopharmaceutical company’s stock after buying an additional 81 shares during the quarter. Tokio Marine Asset Management Co. Ltd.’s holdings in Regeneron Pharmaceuticals were […]
GAMMA Investing LLC bought a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the fourth quarter, Holdings Channel.com reports. The fund bought 730 shares of the biopharmaceutical company’s stock, valued at approximately $688,000. A number of other institutional investors have also made changes to their positions in REGN. Meyer Handelman […]
GAMMA Investing LLC acquired a new stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 730 shares of the biopharmaceutical company’s stock, valued at approximately $688,000. Other institutional investors and hedge funds have […]